LGND
Ligand Pharmaceuticals IncorporatedNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.12B
P/E Ratio
33.27
EPS
$7.68
Beta
1.04
52W High
$259.03
52W Low
$110.00
50-Day MA
$226.13
200-Day MA
$199.39
Dividend Yield
—
Profit Margin
55.90%
Forward P/E
28.65
PEG Ratio
1.53
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs globally. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $274.48M |
| Gross Profit (TTM) | $228.26M |
| EBITDA | $134.45M |
| Operating Margin | 33.60% |
| Return on Equity | 17.10% |
| Return on Assets | 5.19% |
| Revenue/Share (TTM) | $14.07 |
| Book Value | $49.79 |
| Price-to-Book | 5.13 |
| Price-to-Sales (TTM) | 18.66 |
| EV/Revenue | 17.4 |
| EV/EBITDA | 21.35 |
| Quarterly Earnings Growth (YoY) | 103.20% |
| Quarterly Revenue Growth (YoY) | 14.10% |
| Shares Outstanding | $20.04M |
| Float | $19.55M |
| % Insiders | 2.42% |
| % Institutions | 106.33% |
Historical Volatility
HV 10-Day
16.93%
HV 20-Day
29.50%
HV 30-Day
42.37%
HV 60-Day
42.85%
HV Rank
74.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($277.60 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026